James Christopher Barry Nuvasive Inc (NUVA) insider trading activity

James Christopher Barry is Chief Executive Officer of NUVASIVE INC. Currently has a direct ownership of 0 shares of NUVA, which is worth approximately $0. The most recent transaction as insider was on Sep 01, 2023, when has been sold 72,997 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

James Christopher Barry Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 01 2023	SELL Sale (or disposition) back to the issuer	-	72,997 Reduced 100.0%	0 Common Stock, par valu...
Mar 01 2023	SELL Payment of exercise price or tax liability	$490,918 $42.67 p/Share	11,505 Reduced 13.62%	72,997 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	34,284 Added 28.86%	84,502 Common Stock
Apr 13 2022	SELL Open market or private sale	$290,000 $58.0 p/Share	5,000 Reduced 9.06%	50,218 Common Stock
Mar 28 2022	SELL Open market or private sale	$275,000 $55.0 p/Share	5,000 Reduced 8.3%	55,218 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$1,133,372 $54.51 p/Share	20,792 Reduced 25.67%	60,218 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	53,523 Added 39.78%	81,010 Common Stock
Nov 05 2021	SELL Payment of exercise price or tax liability	$708,488 $57.4 p/Share	12,343 Reduced 30.99%	27,487 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	-	29,904 Added 42.88%	39,830 Common Stock
Jun 25 2021	SELL Open market or private sale	$350,000 $70.0 p/Share	5,000 Reduced 33.5%	9,926 Common Stock
Jun 21 2021	SELL Open market or private sale	$340,000 $68.0 p/Share	5,000 Reduced 25.09%	14,926 Common Stock
Nov 05 2020	SELL Payment of exercise price or tax liability	$352,570 $44.68 p/Share	7,891 Reduced 28.37%	19,926 Common Stock
Nov 05 2020	BUY Exercise of conversion of derivative security	-	17,944 Added 39.21%	27,817 Common Stock

Also insider at

LIVN

LivaNova PLC Healthcare

Director

JCB